Corventis, Inc

Corventis, Inc. specializes in wireless cardiovascular solutions that enhance the early detection and monitoring of heart conditions. Their technology is designed to be user-friendly for both patients and physicians, enabling efficient remote cardiac monitoring. The company's flagship product, the Nuvant Mobile Cardiac Telemetry (MCT) system, received FDA clearance in 2010. This system allows for continuous, real-time cardiac monitoring outside of traditional clinical settings, facilitating the early identification of arrhythmias and other cardiac events. It provides healthcare professionals with detailed cardiac data to support the diagnosis and management of patients with suspected or known cardiac arrhythmias. Corventis primarily serves healthcare providers, including cardiologists and hospitals, focusing on advanced cardiac monitoring solutions that improve patient outcomes. Their technology is essential for managing chronic cardiovascular conditions and reducing hospital visits, emphasizing patient-centered, technology-driven cardiac care.

• Employees 10
• Founded 2005
• Annual Revenue $21141000